| BRIEF COMMUNICATIONS |
|
| Year : 2005 | Volume
: 1
| Issue : 2 | Page : 108-110 |
|
|
A three way complex translocation (4;9;22) in two patients with chronic myelocytic leukemia
Frenny J Sheth1, Jayesh J Sheth1, Alain Verhest2
1 FRIGE (Foundation for Research in Genetics and Endocrinology) Genetic Centre, 20/1, Bima Nagar, Satellite, Ahmedabad-380 015, India
2 Laboratorie de Cytogenetique Institut Jules Bordet Cancer Center of the free University of Brussels (ULB) 1000 Brussels, Belgium
Correspondence Address:
Frenny J Sheth
FRIGE (Foundation for Research in Genetics and Endocrinology) Genetic Centre, 20/1, Bima Nagar, Satellite, Ahmedabad-380 015
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0973-1482.16711
|
|
|
Chronic myeloid leukemia (CML) is genetically characterized by the reciprocal translocation of chromosome 9 and 22, t(9;22)(q34;q11) which results in the fusion of BCR/ABL gene observed on the derivative chromosome 22 called Philadelphia (Ph') chromosome. About 5-8% of Philadelphia positive patients with CML show various complex translocations involving third chromosome in addition to chromosome 9 and 22. In present report we discuss two cases with CML referred at our centre. At the time of initial diagnosis and after 9 months of treatment, one of the patients showed 100% presence of Philadelphia positive in bone marrow culture. During follow-up in an accelerated state, his cytogenetic study revealed a complex translocation (4;9;22)(q25;q34;q11) along with an additional Philadelphia and marker chromosome. The second patient showed a complex (4;9;22)(q25;q34;q11) translocation at the time of diagnosis. He was on hydroxyurea and his follow-up cytogenetic study after the course of chemotherapy showed no changes. Further confirmation of complex translocation was done by FISH study using bcr/abl and whole chromosome 9 probes. Though the additional genes involved in complex variant Ph' rearrangements have not been characterized, both patients are healthy till 3 to 5 years of initial diagnosis. This could be attributed to the benign effect resulted from reciprocal translocation with no loss or gain of the genetic material.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
